Maharashtra FDA Flags High Markups on Medical Devices, Seeks Pricing Review
Maharashtra FDA Commissioner Tukaram Mundhe has highlighted significant markups on medical devices and hospital consumables, with a state survey revealing price differences up to 2,841% between trade prices and MRPs. He has urged the Department of Pharmaceuticals and NPPA to review pricing rules, cap trade margins, and consider structured price monitoring for essential devices. The Association of Indian Medical Device Industry supports this call, emphasizing the need for affordable and transparent pricing to protect patients who cannot compare or question costs during treatment.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. Coverage leans balanced overall (Left 0%, Centre 51%, Right 49%). Overall sentiment is neutral (51/100). Lens Score 62/100.
Outlets measured: moneycontrol, mint. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
All 2 outlets scored close to centre on political lean. The real divergence here is in emphasis, not lean — compare the headlines below to see how each outlet chose to frame the same facts.
Sentiment was consistent across outlets (48–48/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
mint broke this story on 15 Sept, 12:20 am. Other outlets followed.